EP
PRTA icon

Evelyn Partners’s Prothena Corp PRTA Stock Holding History

Evelyn Partners’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Buy
+199
New +$1.97K ﹤0.01% 529

Other funds holding PRTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evelyn Partners's PRTA Position: Q2 2026 in Review

Evelyn Partners opened a new position in Prothena Corp (PRTA) in Q2 2026: 199 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #529 among its holdings.

173 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Evelyn Partners held 199 shares of Prothena Corp worth $1.95K as of Q2 2026.
  • Prothena Corp was a new Evelyn Partners position in Q2 2026.
  • Prothena Corp made up ﹤0.01% of Evelyn Partners's portfolio in Q2 2026, its #529 holding.
  • 173 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.